By mimicking endogenous GLP-1, semaglutide enhances glucose-dependent insulin secretion, suppresses glucagon release, and significantly reduces appetite through central nervous system pathways
Subcutaneous abdominal fat (the fat under your skin) also fell by 13.2% to 43.5%
Use the arrows to see more real patient stories 4,500+ patients and counting have changed their lives with MDWatch Check your Medicare benefits See if you qualify in minutes free, with no obligation
According to the company: "Like an intensive workout." Except not, because you're lying down not perspiring or panting or wishing for death to come, as one does during a killer sweat sesh
Some users have reported issues like anxiety, fatigue, and changes in heart rate, but these are just anecdotal accounts
AOD 9604 is not FDA-approved as a pharmaceutical drug